Peptide Pipeline
Assets
Companies
Trials
Landscapes
Targets
Indications
Modalities
Deals
Approvals
Catalysts
Reports
Get the Brief
Indications
indication
Type 2 diabetes
Metabolic disease
15 assets
indication
Obesity
Metabolic disease
15 assets
indication
NASH/MASH
Liver/metabolic disease
4 assets
indication
Cardiovascular risk reduction
Cardiometabolic disease
2 assets